Specialists for Primary effusion lymphoma

19 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Richard F. Little, MD
Rare Disease / Clinical Research
NCI - HIV and AIDS Malignancy Branch
QC-verified PI×1
Robert Yarchoan, M.D.
Rare Disease Specialist
National Cancer Institute (NCI)
Bethesda, Maryland
PI×13
Ramya M Ramaswami, M.D.
Rare Disease Specialist
National Cancer Institute (NCI)
Bethesda, Maryland
PI×10
Pei Wang, PhD
Rare Disease / Clinical Research
Eureka Therapeutics Inc.
PI×4
Wyndham H Wilson, M.D., MD, PhD
Rare Disease / Clinical Research
National Cancer Institute (NCI)
BETHESDA, MD
PI×8
Stephen M Ansell, M.D
Rare Disease / Clinical Research
Dana-Farber - Harvard Cancer Center LAO
ROCHESTER, MN
PI×1 5
Veronika Bachanova, MD, MD
Rare Disease / Clinical Research
Masonic Cancer Center, University of Minnesota
MINNEAPOLIS, MN
PI×5
Frank G Basile, M.D., MD
Rare Disease / Clinical Research
Schrodinger Inc.
RIVERSIDE, RI
PI×1
Ramya Ramaswami, M.D., MD MPH
Rare Disease / Clinical Research
National Cancer Institute (NCI)
BETHESDA, MD
PI×1
Amrita Krishnan, MD
Rare Disease / Clinical Research
City of Hope Medical Center
DUARTE, CA
PI×2 61
Amrita Krishnan, MD, MD
Rare Disease / Clinical Research
City of Hope Medical Center
DUARTE, CA
PI×2 1
Mark J. Roschewski, MD, MD
Rare Disease / Clinical Research
NCI Lymphoid Malignancy Branch
WASHINGTON, DC
PI×1
Juan C Ramos
Rare Disease / Clinical Research
AIDS Malignancy Consortium
PI×1 37
Thomas Witzig, M.D
Rare Disease / Clinical Research
Mayo Clinic
ROCHESTER, MN
PI×5
Robert Strother
Rare Disease / Clinical Research
AIDS Associated Malignancies Clinical Trials Consortium
PI×1
Matthew Cheung, Dr. .
Rare Disease / Clinical Research
Odette Cancer Centre
PI×1 40
Ida C Wong-Sefidan, M.D
Rare Disease / Clinical Research
AIDS Malignancy Consortium
SAN DIEGO, CA
PI×1
Chet Bohac, PharmD, MD, MSc
Rare Disease / Clinical Research
Executive Medical Director, Clinical Development, Xencor, Inc.
PI×1
Richard Ambinder, M.D., M.D
Rare Disease / Clinical Research
Johns Hopkins University
BALTIMORE, MD
PI×2

More about Primary effusion lymphoma